These inspections are adopted by the Committee for Medicinal Products for Veterinary Use (CVMP). They may be routine, or triggered by issues arising during the assessment of pharmacovigilance data or by other information such as previous inspection experience.

For more information on pharmacovigilance inspections and EMA's role, please refer to the content in the human regulatory section:

If you have questions regarding this content, Send a question to the European Medicines Agency

Inspection procedures

Superseded - inspection procedures

Share this page